NCT03581305View on ClinicalTrials.gov

PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 20, 2018

Primary Completion Date

April 6, 2022

Study Completion Date

April 6, 2022

Conditions
DepressionHIV InfectionsHIV-Associated Cognitive Motor Complex
Interventions
DRUG

18F-FDOPA

High resolution positron emission tomography (PET) of the brain and radioligands targeted against the dopaminergic (18F-FDOPA) system.

DRUG

11C-DASB

High resolution positron emission tomography (PET) of the brain and radioligands targeted against the serotonergic (11C-DASB) system.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT03581305 - PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects | Biotech Hunter | Biotech Hunter